Ikgdar 500mg Injection
Marketer
Cipla Ltd
Salt Composition
Rituximab (500mg)
Overview Ikgdar 500mg Injection
Rituximab 500mg injection treats several conditions, including non-Hodgkin's lymphoma, rheumatoid arthritis, chronic lymphocytic leukemia, granulomatosis with polyangiitis, and microscopic polyangiitis. Administered intravenously under medical supervision, dosage and frequency are determined by your physician based on your specific condition and may vary. Precise adherence to the prescribed regimen is crucial to avoid severe adverse effects. Therapeutic benefits might not be immediately apparent, requiring weeks or months; discontinue only under medical guidance. Common side effects include headache, fatigue, swelling, infections, and alopecia. Rituximab can lower blood cell counts, increasing infection risk, necessitating regular blood tests, including hepatitis B monitoring. Prior to treatment, inform your doctor about pre-existing heart or liver conditions, upcoming surgeries or vaccinations, and all other medications, including those for infections. Interactions with other drugs are possible. Avoid pregnancy during treatment; effective contraception is vital for both partners. A patient support program exists in India, facilitated by Tata 1mg; contact your physician or call (1800-102-1618) for further information.
Primary Ingredients of Ikgdar 500mg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Ikgdar 500mg Injection
Chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, microscopic polyangiitis, and non-Hodgkin lymphoma.
Major Benefits of Ikgdar 500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ikgdar 500mg Injection:
- Headache
- Weakness
- Infection
- Chills
- Decreased white blood cell count (neutrophils)
- Fever
- Infusion site reaction
- Lymphopenia
- Abdominal pain
- Back pain
How to use Ikgdar 500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Ikgdar 500mg Injection works:
Ikgdar 500mg Injection, a monoclonal antibody therapy, neutralizes the aberrant activity of B lymphocytes, providing relief in rheumatoid arthritis and specific cancers.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol alongside Ikgdar 500mg Injection requires careful consideration. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Administering Ikgdar 500mg Injection during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to any prescription. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Administration of Ikgdar 500mg Injection while breastfeeding appears to pose minimal risk. Available human data indicates negligible infant hazard.
DrivingCONSULT YOUR DOCTOR
The effect of Ikgdar 500mg Injection on driving ability is unknown. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Ikgdar 500mg Injection appears to pose minimal risk for individuals with impaired renal function. Preliminary evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Data regarding Ikgdar 500mg Injection's use in individuals with hepatic impairment is scarce. Physician consultation is advised. Ikgdar 500mg Injection is contraindicated for patients experiencing active liver disease or a history of viral hepatitis due to the potential for infection recurrence.
What if you forget to take Ikgdar 500mg Injection :
Omit doses of Ikgdar 500mg Injection only after contacting your physician.
Facts to Know About Ikgdar 500mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Behavior Class | Anti-CD20 Therapy |

